Navigation Links
Relieving chronic pain
Date:3/25/2013

Each year, more than 35,000 patients in the United States are implanted with spinal cord stimulators to treat chronic pain. Unfortunately, up to half of such patients receive only very limited pain relief. To help more patients, scientists are developing a new device to deliver therapeutic stimulation in a more targeted way, reaching nerve fibers deep within the spinal cord.

Standard devices, first introduced in 1967, work by delivering a low electrical current to the spinal cord that interferes with the body's pain signals. Such devices, however, are only able to deliver therapeutic current to a thin layer of nerve fibers along the outside of the spinal cord. That's because the electrodes delivering the current are placed within the cerebrospinal fluid, which is itself conductive and so dissipates some of the current.

The new device, called the Human Spinal Cord Modulation System (HSCMS), is designed to be in direct contact with the spinal cord, held in place by a small loop of wire. Because the spinal cord moves during normal patient activity, that loop has to exert enough pressure for the HSCMS to stay in contact with the spinal cord but not so much that the pressure restricts blood flow or causes direct injury.

To test the pressure exerted by the HSCMS's design, researchers attached the device to a silicone model of the spinal cord previously developed to have the same biomechanical characteristics as living tissue. They then slowly compressed the loop, measuring the pressure exerted on the silicone model. The results, which were accepted for publication in the American Institute of Physics (AIP) Journal of Applied Physics, show the device's loop design exerts pressure at a similar level as is normally found on the spinal cords of healthy people, and so passes an important safety test for further development of the device.


'/>"/>
Contact: Catherine Meyers
cmeyers@aip.org
301-209-3088
American Institute of Physics
Source:Eurekalert

Page: 1

Related biology news :

1. Relieving plant stress could eventually help humans relax
2. Are survivors of childhood leukemia and lymphoma at greater risk of chronic fatigue as adults?
3. NIH awards nearly $2 million to 3 NYC institutions for chronic fatigue syndrome research
4. Preventing chronic pain with stress management
5. Virology researcher awarded nearly $2 million to study chronic hepatitis E
6. Loneliness, like chronic stress, taxes the immune system
7. Chronic disease research awarded funding
8. Social synchronicity
9. Chronic kidney disease increases risk of death at all ages
10. Viruses not to blame for chronic fatigue syndrome after all
11. B cell survival holds key to chronic graft vs. host disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
Breaking Biology Technology: